Vaccine. 2008 Nov 5;26(47):5922-7. Epub 2008 Sep 17.

First administration to humans of a monoclonal antibody cocktail against rabies virus: safety, tolerability, and neutralizing activity.

Bakker AB, Python C, Kissling CJ, Pandya P, Marissen WE, Brink MF, Lagerwerf F, Worst S, van Corven E, Kostense S, Hartmann K, Weverling GJ, Uytdehaag F, Herzog C, Briggs DJ, Rupprecht CE, Grimaldi R, Goudsmit J.

Source

Crucell Holland BV, Leiden, The Netherlands. lex.bakker@crucell.com

Abstract

Immediate passive immune prophylaxis as part of rabies post-exposure prophylaxis (PEP) often cannot be provided due to limited availability of human or equine rabies immunoglobulin (HRIG and ERIG, respectively). We report first clinical data from two phase I studies evaluating a monoclonal antibody cocktail CL184 against rabies. The studies included healthy adult subjects in the USA and India and involved two parts. First, subjects received a single intramuscular dose of CL184 or placebo in a double blind, randomized, dose-escalation trial. Second, open-label CL184 (20IU/kg) was co-administered with rabies vaccine. Safety was the primary objective and rabies virus neutralizing activity (RVNA) was investigated as efficacy parameter. Pain at the CL184 injection site was reported by less than 40% of subjects; no fever or local induration, redness or swelling was observed. RVNA was detectable from day 1 to day 21 after a single dose of CL184 20 or 40IU/kg. All subjects had adequate (>0.5IU/mL) RVNA levels from day 14 onwards when combined with rabies vaccine. CL184 appears promising as an alternative to RIG in PEP.

PMID:: 18804136; [PubMed - indexed for MEDLINE]

LinkOut - more resources

Full Text Sources

Other Literature Sources

Labome Researcher Resource - ExactAntigen/Labome

Medical

Rabies - MedlinePlus Health Information

Supplemental Content

Save items

Related citations in PubMed

Evaluation of the safety and immunogenicity of a new, heat-treated human rabies immune globulin using a sham, post-exposure prophylaxis of rabies. [Biologicals. 1998]
Evaluation of the safety and immunogenicity of a new, heat-treated human rabies immune globulin using a sham, post-exposure prophylaxis of rabies.
Lang J, Gravenstein S, Briggs D, Miller B, Froeschle J, Dukes C, Le Mener V, Lutsch C. Biologicals. 1998 Mar; 26(1):7-15.
Evaluation of the safety, immunogenicity, and pharmacokinetic profile of a new, highly purified, heat-treated equine rabies immunoglobulin, administered either alone or in association with a purified, Vero-cell rabies vaccine. [Acta Trop. 1998]
Evaluation of the safety, immunogenicity, and pharmacokinetic profile of a new, highly purified, heat-treated equine rabies immunoglobulin, administered either alone or in association with a purified, Vero-cell rabies vaccine.
Lang J, Attanath P, Quiambao B, Singhasivanon V, Chanthavanich P, Montalban C, Lutsch C, Pepin-Covatta S, Le Mener V, Miranda M, et al. Acta Trop. 1998 Jul 30; 70(3):317-33.
Immunogenicity and effectiveness of post-exposure rabies prophylaxis with a new chromatographically purified Vero-cell rabies vaccine (CPRV): a two-stage randomised clinical trial in the Philippines. [Acta Trop. 2000]
Immunogenicity and effectiveness of post-exposure rabies prophylaxis with a new chromatographically purified Vero-cell rabies vaccine (CPRV): a two-stage randomised clinical trial in the Philippines.
Quiambao BP, Lang J, Vital S, Montalban CG, Le Mener V, Wood SC, Miranda E. Acta Trop. 2000 Feb 25; 75(1):39-52.
Review Human monoclonal antibody and vaccine approaches to prevent human rabies. [Curr Top Microbiol Immunol. 2008]
Review Human monoclonal antibody and vaccine approaches to prevent human rabies.
Nagarajan T, Rupprecht CE, Dessain SK, Rangarajan PN, Thiagarajan D, Srinivasan VA. Curr Top Microbiol Immunol. 2008; 317:67-101.
Review Preventing rabies with the Verorab vaccine: 1985-2005 Twenty years of clinical experience. [Travel Med Infect Dis. 2007]
Review Preventing rabies with the Verorab vaccine: 1985-2005 Twenty years of clinical experience.
Toovey S. Travel Med Infect Dis. 2007 Nov; 5(6):327-48. Epub 2007 Sep 17.

See reviews... See all...

Cited by 5 PubMed Central articles

Review Molecular Pharming: future targets and aspirations. [Hum Vaccin. 2011]
Review Molecular Pharming: future targets and aspirations.
Paul M, van Dolleweerd C, Drake PM, Reljic R, Thangaraj H, Barbi T, Stylianou E, Pepponi I, Both L, Hehle V, et al. Hum Vaccin. 2011 Mar; 7(3):375-82. Epub 2011 Mar 1.
Rabies, still neglected after 125 years of vaccination. [PLoS Negl Trop Dis. 2010]
Rabies, still neglected after 125 years of vaccination.
Bourhy H, Dautry-Varsat A, Hotez PJ, Salomon J. PLoS Negl Trop Dis. 2010 Nov 30; 4(11):e839. Epub 2010 Nov 30.
Review Monoclonal antibody-based therapies for microbial diseases. [Vaccine. 2009]
Review Monoclonal antibody-based therapies for microbial diseases.
Saylor C, Dadachova E, Casadevall A. Vaccine. 2009 Dec 30; 27 Suppl 6:G38-46.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

First administration to humans of a monoclonal antibody cocktail against rabies ...
First administration to humans of a monoclonal antibody cocktail against rabies virus: safety, tolerability, and neutralizing activity.
Vaccine. 2008 Nov 5 ;26(47):5922-7. Epub 2008 Sep 17 .

PubMed
Clinical assessment of the deep cervical flexor muscles: the craniocervical flex...
Clinical assessment of the deep cervical flexor muscles: the craniocervical flexion test.
J Manipulative Physiol Ther. 2008 Sep ;31(7):525-33.

PubMed
Efficacy and tolerability of exenatide monotherapy over 24 weeks in antidiabetic...
Efficacy and tolerability of exenatide monotherapy over 24 weeks in antidiabetic drug-naive patients with type 2 diabetes: a randomized, double-blind, placebo-controlled, parallel-group study.
Clin Ther. 2008 Aug ;30(8):1448-60.

PubMed
Prenatal imprinting of postnatal specific appetites and feeding behavior.
Prenatal imprinting of postnatal specific appetites and feeding behavior.
Metabolism. 2008 Oct ;57 Suppl 2:S22-6.

PubMed
Independent and opposite associations of hip and waist circumference with metabo...
Independent and opposite associations of hip and waist circumference with metabolic syndrome components and with inflammatory and atherothrombotic risk factors in overweight and obese women.
Metabolism. 2008 Oct ;57(10):1315-22.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to:

First administration to humans of a monoclonal antibody cocktail against rabies virus: safety, tolerability, and neutralizing activity.

Source

Abstract

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Supplemental Content

Save items

Related citations in PubMed

Cited by 5 PubMed Central articles

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information